In CRC, low PTEN expression has been associated with several negative outcomes such as a more advanced tumor-node-metastasis (TNM) stage, higher incidence of lymph node metastasis, and an increased chance of local recurrence [9]. This evidence concerns the gene PTEN and neoplasm.